Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03371992
Title Pilot Study of Nilogen 3D-EX and Its Ability to Predict Therapeutic Response to Anti-PD1 or Anti-PDL1 in NSCLC (NO3DEXPL)
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Nilogen Oncosystems
Indications

lung non-small cell carcinoma

Therapies

Nivolumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.